Search | Page 6 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Pure Red Cell Aplasia (PRCA)

    Pure Red Cell Aplasia (PRCA) ... precursors (reticulocytes) in the marrow and a low red blood cell count. The amounts of white blood cells and platelet ...

    Topic section last updated 07/07/2016 - 3:14pm.

  2. Polymorphism of the complement receptor 1 gene correlates with hematological response to eculizumab in patients with paroxysmal nocturnal hemoglobinuria

    ... the response is variable and some patients remain red blood cell transfusion -dependent. In 72 patients with hemolytic Paroxysmal ...

    Research Article last updated 09/26/2013 - 3:28pm.

  3. Clinical utility of lenalidomide in the treatment of myelodysplastic syndromes

    ... Journal Title:  J Blood Med Primary Author:  ... of patients with del(5q) MDS, including reduction in red blood cell transfusion requirements and improvements in quality of ...

    Research Article last updated 03/02/2015 - 2:11pm.

  4. Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab

    ... Journal Title:  Blood Primary Author:  ... During the study, six patients received at least one red blood cell transfusion . Lack of detectable CH50 activity (defined by ...

    Research Article last updated 01/20/2015 - 2:28pm.

  5. Debby Cook, Feeling at home in the muddy water

    ... when I was no longer neutropenic (low number of white blood cells), we were out for lunch and I saw a sign for a yoga studio.  I ... that I get to be his mom. Today I feel good.  My red blood cell counts, white blood cell counts and platelets are ...

    Patient Chronicle last updated 09/11/2017 - 8:30am.

  6. The Effect of Decitabine Dose Modification and Myelosuppression on Response and Survival in Patients With Myelodysplastic Syndromes

    ... patients with MDS conducted Cox regression analyses of red blood cell or platelet dependence, myelosuppression, dose ...

    Research Article last updated 06/02/2014 - 11:03am.

  7. Jordan Brown - Family’s Support Spurs Recovery

    ... care in Virginia to have the cysts lanced and was given a blood test during the procedure. On Monday July 14th, I received a call at ... back in the normal range, he had taken off his mask and his red count was approaching normal. Jordan decided to go on with life.  He could ...

    Patient Chronicle last updated 10/12/2015 - 8:11am.

  8. Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine.

    ... Journal Title:  Blood Primary Author:  ... cytogenetics , presence of circulating blasts, and red blood cell transfusion dependency ≥ 4 units/8 weeks (all P < 10(-4)) ...

    Research Article last updated 07/28/2014 - 8:53am.

  9. Treatment and outcomes for chronic myelomonocytic leukemia compared to myelodysplastic syndromes in older adults

    ... to Medicare claims. Baseline characteristics, treatment ( red blood cell transfusions, hematopoietic growth factors, hypomethylating ...

    Research Article last updated 11/19/2012 - 2:37pm.

  10. The immunomodulatory agents lenalidomide and thalidomide for treatment of the myelodysplastic syndromes: A clinical practice guideline.

    ... expected with the aging population. Treatment includes red blood cell transfusion for anemia . The immunomodulatory agents ...

    Research Article last updated 10/01/2012 - 10:04am.